89
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Comparison study of physicochemical and biopharmaceutics properties of hydrophobic drugs ground by two dry milling processes

, , &
Pages 816-828 | Received 21 Jul 2022, Accepted 01 Sep 2022, Published online: 12 Sep 2022

References

  • Al-Obaidi H, Lawrence MJ, Shah S, Moghul H, Al-Saden N, Bari F. 2013. Effect of drug–polymer interactions on the aqueous solubility of milled solid dispersions. Int J Pharm. 446(1–2):100–105.
  • Amidon GL, Lennernäs H, Shah VP, Crison JR. 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 12(3):413–420.
  • Borba PAA, Pinotti M, de Campos CEM, Pezzini BR, Stulzer HK. 2016. Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs. Carbohydr Polym. 137:350–359.
  • Branham ML, Moyo T, Govender T. 2012. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement. Eur J Pharm Biopharm. 80(1):194–202.
  • Chamarthy SP, Pinal R. 2008. The nature of crystal disorder in milled pharmaceutical materials. Colloids Surf A. 331(1–2):68–75.
  • Chaudhari SP, Dugar RP. 2017. Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs. J Drug Delivery Sci Technol. 41:68–77.
  • Chaudhary A, Nagaich U, Gulati N, Sharma VK, Khosa RL. 2012. Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: a recent review. J Adv Pharm Educ Res. 2:32–67.
  • Chikhalia V, Forbes RT, Storey RA, Ticehurst M. 2006. The effect of crystal morphology and mill type on milling induced crystal disorder. Eur J Pharm Sci. 27(1):19–26.
  • Columbano A, Buckton G, Wikeley P. 2003. Characterisation of surface modified salbutamol sulphate-alkylpolyglycoside microparticles prepared by spray drying. Int J Pharm. 253(1–2):61–70.
  • Da Silva FLO, Marques MBDF, Kato KC, Carneiro G. 2020. Nanonization techniques to overcome poor water-solubility with drugs. Expert Opin Drug Discov. 15(7):853–864.
  • De Gusseme A, Neves C, Willart JF, Rameau A, Descamps M. 2008. Ordering and disordering of molecular solids upon mechanical milling: the case of fananserine. J Pharm Sci. 97(11):5000–5012.
  • de Paiva Lacerda S, Espitalier F, Hoffart V, Ré MI. 2015. Liquid anti-solvent recrystallization to enhance dissolution of CRS 74, a new antiretroviral drug. Drug Dev Ind Pharm. 41(11):1910–1920.
  • Dedroog S, Huygens C, Van den Mooter G. 2019. Chemically identical but physically different: a comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen. Eur J Pharm Biopharm. 135:1–12.
  • Dujardin N, Willart JF, Dudognon E, Danède F, Descamps M. 2013. Mechanism of solid state amorphization of glucose upon milling. J Phys Chem B. 117(5):1437–1443.
  • Einfalt T, Planinšek O, Hrovat K. 2013. Methods of amorphization and investigation of the amorphous state. Acta Pharm. 63(3):305–334.
  • El-Badry M, Fetih G, Fathy M. 2009. Improvement of solubility and dissolution rate of indomethacin by solid dispersions in gelucire 50/13 and PEG4000. Saudi Pharm J. 17(3):217–225.
  • Feng T, Pinal R, Carvajal MT. 2008. Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin. J Pharm Sci. 97(8):3207–3221.
  • Fix I, Steffens K. 2004. Quantifying low amorphous or crystalline amounts of alpha-lactose-monohydrate using X-ray powder diffraction, near-infrared spectroscopy, and differential scanning calorimetry. Drug Dev Ind Pharm. 30(5):513–523.
  • Friedrich H, Nada A, Bodmeier R. 2005. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers. Drug Dev Ind Pharm. 31(8):719–728.
  • Garg A, Singh S, Rao VU, Bindu K, Balasubramaniam J. 2009. Solid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate. Drug Dev Ind Pharm. 35(4):455–470.
  • Gotor FJ, Achimovicova M, Real C, Balaz P. 2013. Influence of the milling parameters on the mechanical work intensity in planetary mills. Powder Technol. 233:1–7.
  • Guo Y, Shalaev E, Smith S. 2013. Physical stability of pharmaceutical formulations: solid-state characterization of amorphous dispersions. TrAC Trends Anal Chem. 49:137–144.
  • Hadjittofis E, Isbell MA, Karde V, Varghese S, Ghoroi C, Heng JYY. 2018. Influences of crystal anisotropy in pharmaceutical process development. Pharm Res. 35(5):100.
  • Hagbani TA, Nazzal S. 2017. Curcumin complexation with cyclodextrins by the autoclave process: method development and characterization of complex formation. Int J Pharm. 520(1–2):173–180.
  • Han X, Ghoroi C, To D, Chen Y, Davé R. 2011. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles. Int J Pharm. 415(1–2):185–195.
  • Humayun HY, Shaarani MNNM, Warrior A, Abdullah B, Salam MA. 2016. The effect of co-solvent on the solubility of a sparingly soluble crystal of benzoic acid. Proc Eng. 148:1320–1325.
  • Hussain A, Smith G, Khan KA, Bukhari NI, Pedge NI, Ermolina I. 2018. Solubility and dissolution rate enhancement of ibuprofen by co-milling with polymeric excipients. Eur J Pharm Sci. 123:395–403.
  • Jermain SV, Brough C, Williams RO. 2018. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – an update. Int J Pharm. 535(1–2):379–392.
  • Jójárt I, Sovány T, Pintye-Hódi K, Kása P. 2012. Study of the behaviour of magnesium stearate with different specific surface areas on the surface of particles during mixing. J Adhes Sci Technol. 26(24):2737–2744.
  • Junyaprasert VB, Morakul B. 2015. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci. 10(1):13–23.
  • Kacso I, Rus L, Pop M, Borodi G, Bratu I. 2012. Structural characterization of ambazone salt with niflumic acid. Spectroscopy. 27(1):49–58.
  • Kho HX, Bae S, Bae S, Kim B-W, Kim JS. 2014. Planetary ball mill process in aspect of milling energy. J Korean Powder Metall Inst. 21(2):155–164.
  • Kumar D, Worku ZA, Gao Y, Kamaraju VK, Glennon B, Babu RP, Healy AM. 2018. Comparison of wet milling and dry milling routes for ibuprofen pharmaceutical crystals and their impact on pharmaceutical and biopharmaceutical properties. Powder Technol. 330:228–238.
  • Kumar R, Thakur AK, Chaudhari P, Banerjee N. 2022. Particle size reduction techniques of pharmaceutical compounds for the enhancement of their dissolution rate and bioavailability. J Pharm Innov. 17(2):333–352.
  • Li J, Yang Y, Zhao M, Xu H, Ma J, Wang S. 2017. Improved oral bioavailability of probucol by dry media-milling. Mater Sci Eng C Mater Biol Appl. 78:780–786.
  • Ling Z, Wang T, Makarem M, Santiago Cintrón M, Cheng HN, Kang X, Bacher M, Potthast A, Rosenau T, King H, et al. 2019. Effects of ball milling on the structure of cotton cellulose. Cellulose. 26(1):305–328.
  • Loftsson T, Brewster ME. 2010. Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol. 62(11):1607–1621.
  • Loh ZH, Samanta AK, Heng PWS. 2015. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci. 10(4):255–274.
  • Mallick S, Pattnaik S, Swain K, De PK, Saha A, Ghoshal G, Mondal A. 2008. Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin. Eur J Pharm Biopharm. 68(2):346–351.
  • Mallick S, Pradhan SK, Mohapatra R. 2013. Effects of microcrystalline cellulose based comilled powder on the compression and dissolution of ibuprofen. Int J Biol Macromol. 60:148–155.
  • Mártha C, Kürti L, Farkas G, Jójárt-Laczkovich O, Szalontai B, Glässer E, Deli MA, Szabó-Révész P. 2013. Effects of polymers on the crystallinity of nanonized meloxicam during a co-grinding process. Eur Polym J. 49(9):2426–2432.
  • Mennini N, Maestrelli F, Cirri M, Mura P. 2016. Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-β-cyclodextrin and l-arginine aimed to improve the drug solubility. J Pharm Biomed Anal. 129:350–358.
  • Mir M, Hayat K, Hussain T, Waqas MK, Bukhari NI. 2018. Ball mill based on co-milling, a promising way to enhance solubility of poorly soluble drugs employing norfloxacin as model drug. Acta Pol Pharm. 75(1):155–168.
  • Newman A, Zografi G. 2014. Critical considerations for the qualitative and quantitative determination of process-induced disorder in crystalline solids. J Pharm Sci. 103(9):2595–2604.
  • Noyes AA, Whitney WR. 1897. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 19(12):930–934.
  • Nugrahani I, Jessica MA. 2021. Amino acids as the potential co-former for co-crystal development: a review. Molecules. 26(11):3279.
  • Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T. 2007. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm. 336(1):22–34.
  • Perissutti B, Passerini N, Trastullo R, Keiser J, Zanolla D, Zingone G, Voinovich D, Albertini B. 2017. An explorative analysis of process and formulation variables affecting comilling in a vibrational mill: the case of praziquantel. Int J Pharm. 533(2):402–412.
  • Phillips EM. 1997. An approach to estimate the amorphous content of pharmaceutical powders using calorimetry with no calibration standards. Int J Pharm. 149(2):267–271.
  • Qin L, Niu Y, Wang Y, Chen X. 2018. Combination of phospholipid complex and submicron emulsion techniques for improving oral bioavailability and therapeutic efficacy of water-insoluble drug. Mol Pharm. 15(3):1238–1247.
  • Sakher E, Loudjani N, Benchiheub M, Bououdina M. 2018. Influence of milling time on structural and microstructural parameters of Ni50 Ti50 prepared by mechanical alloying using Rietveld analysis. J Nanomater. 2018:1–11.
  • Saleki-Gerhardt A, Ahlneck C, Zografi G. 1994. Assessment of disorder in crystalline solids. Int J Pharm. 101(3):237–247.
  • Saravanan D, Muthudoss P, Khullar P, Venis R. 2021. Micronization and agglomeration: understanding the impact of API particle properties on dissolution and permeability using solid state and biopharmaceutical "Toolbox". J Pharm Innov. 16(1):136–151.
  • Serajuddin ATM. 2007. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 59(7):603–616.
  • Sheng JJ, Kasim NA, Chandrasekharan R, Amidon GL. 2006. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant. Eur J Pharm Sci. 29(3–4):306–314.
  • Sud S, Kamath A. 2013. Methods of size reduction and factors affecting size reduction in pharmaceutics. Int Res J Pharm. 4(8):57–64.
  • Szunyogh T, Ambrus R, Szabó-Révész P. 2012. Formation of niflumic acid particle size by solvent diffusion and solvent evaporation as precipitation methods. J Drug Delivery Sci Technol. 22(4):307–312.
  • Szunyogh T, Ambrus R, Szabó-Révész P. 2013. Nanonization of niflumic acid by co-grinding. Adv Nanopart. 2(4):329–335.
  • Taniguchi C, Kawabata Y, Wada K, Yamada S, Onoue S. 2014. Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility. Expert Opin Drug Deliv. 11(4):505–516.
  • Tawfeek HM, Chavan T, Kunda NK. 2020. Effect of spray drying on amorphization of indomethacin nicotinamide cocrystals; optimization, characterization, and stability study. AAPS PharmSciTech. 21:181.
  • Van Duong T, Lüdeker D, Van Bockstal P-J, De Beer T, Van Humbeeck J, Van den Mooter G. 2018. Polymorphism of indomethacin in semicrystalline dispersions: formation, transformation, and segregation. Mol Pharm. 15(3):1037–1051.
  • Venkatesh S, Li J, Xu Y, Vishnuvajjala R, Anderson BD. 1996. Intrinsic solubility estimation and pH-solubility behavior of cosalane NSC 658586, an extremely hydrophobic diprotic acid. Pharm Res. 13(10):1453–1459.
  • Wadhwa J, Nair A, Kumria R. 2012. Emulsion forming drug delivery system for lipophilic drugs. Acta Pol Pharm. 69:179–191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.